Cryptolepis sanguinolenta: antimuscarinic properties of cryptolepine and the alkaloid fraction at M1, M2 and M3 receptors.
From an ethanol extract of the roots of Cryptolepis sanguinolenia the alkaloid fraction and its main constituent cryptolepine were isolated by partitioning at pH 11 and column chromatography using silica gel and chloroform/methanol as eluent. Cryptolepine was identified mainly by EI-MS and 1H/13C-NMR spectroscopy. Cryptolepine (3-30 microM) and the alkaloid fraction of Cryptolepis sanguinolenta (3-10 micrograms/ml) antagonized muscarinic effects at M1 receptors in rabbit vas deferens, M2 receptors in guinea-pig atria, and M3 receptors in guinea-pig ileum. The experiments, using N-methylatropine as reference drug, showed a significant antimuscarinic activity for both cryptolepine and the alkaloid fraction, but no appreciable receptor subtype selectivity (pA2 = 5.00-5.73). Cryptolepine was determined as the antimuscarinic principle of Cryptolepis sanguinolenta. At higher concentrations both materials displayed negative inotropic effects.
Rauwald
H W
HW
Institute of Pharmaceutical Biology, University of Frankfurt, Federal Republic of Germany.
Kober
M
M
Mutschler
E
E
Lambrecht
G
G
D000470:Alkaloids / Q000494:pharmacology*; D000818:Animals; D005260:Female; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D026121:Indole Alkaloids; D007211:Indoles; D008297:Male; D018727:Muscarinic Antagonists; D010946:Plants, Medicinal / Q000737:chemistry*; D011804:Quinolines; D011817:Rabbits; D014649:Vas Deferens / Q000187:drug effects
D000470:Alkaloids; D026121:Indole Alkaloids; D007211:Indoles; D018727:Muscarinic Antagonists; D011804:Quinolines; C024015:cryptolepine